Clinical trial
The Relationship Between Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes
NCT03519529 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Relationship Between Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- April 20, 2018
- Enrollment
- 250 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
type2 diabetes